Science | Page 14 of 29

Cure for Type 1 Diabetes and MS? Discovery of Immune Suppressing Protein CD52

Dr. Harrison and his team identified that some T cells express a molecule on their surfaces, CD52, that is capable of suppressing other T cells. Understanding the ways in which the immune system normally controls and suppresses T cells is crucial to our understanding what goes wrong in autoimmune diseases.

Islet Cell Transplant Progress May Lead to Type 1 Diabetes Cure

The biomaterial holding the islet cells—which is completely synthetic, is 96 percent water, and which Garcia described as having the consistency of diluted Jello-O—and that was infused into the mice, however, addresses several of these problems.

Dee and Bill Brehm: Working Toward a Type 1 Diabetes Cure

One Sunday evening in 1999, as Dee was preparing dinner, Bill entered their kitchen and asked if he could do anything to help her. Dee turned quickly and said defiantly, “You can cure this disease.” Bill was quiet for a moment, and then said, “OK”. So that began their serious quest for a Type 1 diabetes cure and Type 1 diabetes prevention.

Discovery of Betatrophin: A New Hope for Beta Cell Replication

Dr. Doug Melton's group at Harvard, which has made many advances in our understanding of stem cell and beta cell biology over the years, has identified a new hormone, which they called betatrophin, that, when produced by the liver, induces beta cell growth in the islets of the pancreas.

Does Sugar Cause Diabetes?

Does eating too much sugar cause diabetes? It’s not entirely clear, but a population-based study published February 27 in the peer-reviewed, online journal PLoS One identifies a relevant correlation.

An Attempt to Cure Type 1 Diabetes

Of course, given the opportunity cure type 1 diabetes, to eradicate the condition causing me to take insulin injections twice a day, causing me to black out a few times a year, destroying my fingertips with blood sugar testing, and generally making my life unpleasant and inconvenient on one side of the scale and a living hell on the other, I leapt at it.

Diamyd to Launch New Clinical Study of Diabetes Vaccine in Children

Diamyd Medical is planning to launch a new clinical study with its diabetes vaccine, Diamyd, during February 2013. The study, approved by the Swedish Medical Products Agency, combines the diabetes vaccine Diamyd with relatively high doses of vitamin D and the anti-inflammatory drug ibuprofen. The purpose of the treatment is to preserve the body's own ability to control the blood sugar level in children and adolescents newly diagnosed with type 1 diabetes.

Diabetes Research Breakthrough: How Insulin Binds

For more than 20 years scientists have been trying to solve the mystery of how insulin binds to the insulin receptor, a discovery which could help improve treatments for both patients with type 1 and type diabetes. It seems that a research team at the Walter and Eliza Hall Institute in Melbourne, Australia, led by Associate Professor Mike Lawrence, Dr Colin Ward and Dr John Menting have now found the answer.

JDRF and Tandem Team Up to Develop Dual Chamber Infusion Pump as a Step Toward the Artificial Pancreas

JDRF and Tandem Diabetes Care, the company behind the t:slim insulin pump, have teamed up to develop a dual-chamber infusion pump for the management of diabetes. The partnership agreement is designed to accelerate the development of a next-generation, fully automated artificial pancreas system.

What Triggers Type 2 Diabetes? New Research From UCSB

A group of biomedical researchers at UC Santa Barbara is studying the metabolism of cells and their surrounding tissue, to ferret out ways in which certain diseases begin. This approach, which includes computer modeling, can be applied to type 2 diabetes, autoimmune diseases, and neurodegenerative diseases, among others.